Zhang C, Pu K. Molecular and nanoengineering approaches towards activatable cancer immunotherapy.
Chem Soc Rev 2020;
49:4234-4253. [DOI:
10.1039/c9cs00773c]
[Citation(s) in RCA: 154] [Impact Index Per Article: 38.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
This review summarizes the development of activatable immunotherapeutic nanoagents that activate antitumor immunity only in response to internal or external stimuli, which potentially enhance patient response rates while reducing immune-related adverse events during cancer immunotherapy.
Collapse